Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain

The invention discloses a Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as a preparation method and application of the Newcastle disease virus attenuated strain. The attenuated strain is constructed by inserting an infectious bur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FANG JINGZHEN, YU ZEKUN, LI YANLI, WANG TINGTING, ZHOU SHENG, LI SIFEI, DUAN XIAOXIAO, LUAN ZHIFANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FANG JINGZHEN
YU ZEKUN
LI YANLI
WANG TINGTING
ZHOU SHENG
LI SIFEI
DUAN XIAOXIAO
LUAN ZHIFANG
description The invention discloses a Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as a preparation method and application of the Newcastle disease virus attenuated strain. The attenuated strain is constructed by inserting an infectious bursal disease virus variant VP2 protein gene between P-M genes of an NDV gene VII type attenuated strain rSL strain. The preparation method comprises the following steps: firstly introducing a restriction enzyme cutting site between P-M protein genes of a genome main plasmid of an NDV gene VII type attenuated strain rSL strain, and then inserting a sequence containing an infectious bursal disease virus variant VP2 protein gene and the restriction enzyme cutting site between the P-M protein genes in a homologous recombination manner to construct a complete recombinant genome main plasmid; and co-transfecting BHK cells by using the main plasmid and three auxiliary plasmids for respectively expressing N, P and L protein
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116064424A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116064424A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116064424A3</originalsourceid><addsrcrecordid>eNqNjr0KwkAQhNNYiPoO6wMI_gR7CYpVsBBbWZOJHpx3x-0m8Q19LU-0srIYBoaPjxlmzxJ9xaIWVBsBC6gzsRViVbiWFTWJRjaOGh8JjxAhYtyVjGtQqfGJvbRR2P4IOo6GndLpsKQQvSIpWKiHte9OnsCRk8DRHXrzNbFLCcGa6jP7hv5-N84GDVvB5NujbLrbHov9DMGfIYErOOi5KBeL9Xyd58t8s_qHeQG-_GU0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain</title><source>esp@cenet</source><creator>FANG JINGZHEN ; YU ZEKUN ; LI YANLI ; WANG TINGTING ; ZHOU SHENG ; LI SIFEI ; DUAN XIAOXIAO ; LUAN ZHIFANG</creator><creatorcontrib>FANG JINGZHEN ; YU ZEKUN ; LI YANLI ; WANG TINGTING ; ZHOU SHENG ; LI SIFEI ; DUAN XIAOXIAO ; LUAN ZHIFANG</creatorcontrib><description>The invention discloses a Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as a preparation method and application of the Newcastle disease virus attenuated strain. The attenuated strain is constructed by inserting an infectious bursal disease virus variant VP2 protein gene between P-M genes of an NDV gene VII type attenuated strain rSL strain. The preparation method comprises the following steps: firstly introducing a restriction enzyme cutting site between P-M protein genes of a genome main plasmid of an NDV gene VII type attenuated strain rSL strain, and then inserting a sequence containing an infectious bursal disease virus variant VP2 protein gene and the restriction enzyme cutting site between the P-M protein genes in a homologous recombination manner to construct a complete recombinant genome main plasmid; and co-transfecting BHK cells by using the main plasmid and three auxiliary plasmids for respectively expressing N, P and L protein</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230505&amp;DB=EPODOC&amp;CC=CN&amp;NR=116064424A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230505&amp;DB=EPODOC&amp;CC=CN&amp;NR=116064424A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FANG JINGZHEN</creatorcontrib><creatorcontrib>YU ZEKUN</creatorcontrib><creatorcontrib>LI YANLI</creatorcontrib><creatorcontrib>WANG TINGTING</creatorcontrib><creatorcontrib>ZHOU SHENG</creatorcontrib><creatorcontrib>LI SIFEI</creatorcontrib><creatorcontrib>DUAN XIAOXIAO</creatorcontrib><creatorcontrib>LUAN ZHIFANG</creatorcontrib><title>Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain</title><description>The invention discloses a Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as a preparation method and application of the Newcastle disease virus attenuated strain. The attenuated strain is constructed by inserting an infectious bursal disease virus variant VP2 protein gene between P-M genes of an NDV gene VII type attenuated strain rSL strain. The preparation method comprises the following steps: firstly introducing a restriction enzyme cutting site between P-M protein genes of a genome main plasmid of an NDV gene VII type attenuated strain rSL strain, and then inserting a sequence containing an infectious bursal disease virus variant VP2 protein gene and the restriction enzyme cutting site between the P-M protein genes in a homologous recombination manner to construct a complete recombinant genome main plasmid; and co-transfecting BHK cells by using the main plasmid and three auxiliary plasmids for respectively expressing N, P and L protein</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjr0KwkAQhNNYiPoO6wMI_gR7CYpVsBBbWZOJHpx3x-0m8Q19LU-0srIYBoaPjxlmzxJ9xaIWVBsBC6gzsRViVbiWFTWJRjaOGh8JjxAhYtyVjGtQqfGJvbRR2P4IOo6GndLpsKQQvSIpWKiHte9OnsCRk8DRHXrzNbFLCcGa6jP7hv5-N84GDVvB5NujbLrbHov9DMGfIYErOOi5KBeL9Xyd58t8s_qHeQG-_GU0</recordid><startdate>20230505</startdate><enddate>20230505</enddate><creator>FANG JINGZHEN</creator><creator>YU ZEKUN</creator><creator>LI YANLI</creator><creator>WANG TINGTING</creator><creator>ZHOU SHENG</creator><creator>LI SIFEI</creator><creator>DUAN XIAOXIAO</creator><creator>LUAN ZHIFANG</creator><scope>EVB</scope></search><sort><creationdate>20230505</creationdate><title>Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain</title><author>FANG JINGZHEN ; YU ZEKUN ; LI YANLI ; WANG TINGTING ; ZHOU SHENG ; LI SIFEI ; DUAN XIAOXIAO ; LUAN ZHIFANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116064424A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>FANG JINGZHEN</creatorcontrib><creatorcontrib>YU ZEKUN</creatorcontrib><creatorcontrib>LI YANLI</creatorcontrib><creatorcontrib>WANG TINGTING</creatorcontrib><creatorcontrib>ZHOU SHENG</creatorcontrib><creatorcontrib>LI SIFEI</creatorcontrib><creatorcontrib>DUAN XIAOXIAO</creatorcontrib><creatorcontrib>LUAN ZHIFANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FANG JINGZHEN</au><au>YU ZEKUN</au><au>LI YANLI</au><au>WANG TINGTING</au><au>ZHOU SHENG</au><au>LI SIFEI</au><au>DUAN XIAOXIAO</au><au>LUAN ZHIFANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain</title><date>2023-05-05</date><risdate>2023</risdate><abstract>The invention discloses a Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as a preparation method and application of the Newcastle disease virus attenuated strain. The attenuated strain is constructed by inserting an infectious bursal disease virus variant VP2 protein gene between P-M genes of an NDV gene VII type attenuated strain rSL strain. The preparation method comprises the following steps: firstly introducing a restriction enzyme cutting site between P-M protein genes of a genome main plasmid of an NDV gene VII type attenuated strain rSL strain, and then inserting a sequence containing an infectious bursal disease virus variant VP2 protein gene and the restriction enzyme cutting site between the P-M protein genes in a homologous recombination manner to construct a complete recombinant genome main plasmid; and co-transfecting BHK cells by using the main plasmid and three auxiliary plasmids for respectively expressing N, P and L protein</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116064424A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Newcastle disease virus attenuated strain for expressing infectious bursal disease virus variant VP2 protein as well as preparation method and application of Newcastle disease virus attenuated strain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T05%3A10%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FANG%20JINGZHEN&rft.date=2023-05-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116064424A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true